Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) FCF Margin (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of FCF Margin data on record, last reported at 272.06% in Q3 2025.

  • For Q3 2025, FCF Margin rose 6585.0% year-over-year to 272.06%; the TTM value through Sep 2025 reached 585.09%, down 58365.0%, while the annual FY2024 figure was 3.82%, N/A changed from the prior year.
  • FCF Margin reached 272.06% in Q3 2025 per GOSS's latest filing, up from 410.08% in the prior quarter.
  • Across five years, FCF Margin topped out at 1547.16% in Q1 2022 and bottomed at 410.08% in Q2 2025.
  • Average FCF Margin over 4 years is 593.77%, with a median of 749.96% recorded in 2023.
  • Peak YoY movement for FCF Margin: crashed -136973bps in 2024, then skyrocketed 6585bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 1391.12% in 2022, then fell by -26bps to 1031.83% in 2023, then plummeted by -55bps to 468.09% in 2024, then tumbled by -158bps to 272.06% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 272.06% in Q3 2025, 410.08% in Q2 2025, and 401.96% in Q1 2025.